Diabetes in Aging Populations

The management of diabetes in aging populations presents unique challenges due to physiological changes, comorbidities, and polypharmacy. Older adults with diabetes face an increased risk of cognitive decline, cardiovascular disease, and frailty, requiring tailored treatment approaches. Glycemic targets must balance the risks of hypoglycemia and complications while considering functional status and life expectancy. Emerging research highlights the role of personalized nutrition, physical activity, and advanced pharmacological strategies in maintaining metabolic stability. Additionally, geriatric care models integrating endocrinology and geriatrics are essential for optimizing outcomes. As life expectancy increases, innovative healthcare policies and interventions are needed to address the complexities of diabetes management in the elderly.

Committee Members
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes 2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes 2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp